1-(5-乙基-2-羟基-4-((6-甲基-6-(2H-四唑-5-基)庚基)氧基)苯基)乙-1-酮结构式
|
常用名 | 1-(5-乙基-2-羟基-4-((6-甲基-6-(2H-四唑-5-基)庚基)氧基)苯基)乙-1-酮 | 英文名 | LY255283 |
---|---|---|---|---|
CAS号 | 117690-79-6 | 分子量 | 360.451 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 573.4±60.0 °C at 760 mmHg | |
分子式 | C19H28N4O3 | 熔点 | 160-162 °C | |
MSDS | 美版 | 闪点 | 300.6±32.9 °C |
用途LY255283 是 LTB4 受体 (BLT2) 的拮抗剂,其抑制 [3H]LTB4 结合到豚鼠肺膜的 IC50 值约为 100 nM。 |
中文名 | 1-[5-乙基-2-羟基-4-[[6-甲基-6-(1H-四唑-5-基)庚基]氧基]苯基]乙酮 |
---|---|
英文名 | 1-[5-ethyl-2-hydroxy-4-[6-methyl-6-(2H-tetrazol-5-yl)heptoxy]phenyl]ethanone |
英文别名 | 更多 |
描述 | LY255283 是 LTB4 受体 (BLT2) 的拮抗剂,其抑制 [3H]LTB4 结合到豚鼠肺膜的 IC50 值约为 100 nM。 |
---|---|
相关类别 | |
靶点 |
LTB4:~100 nM (IC50, LTB4 binds to guinea pig lung membranes) |
体外研究 | LY255283完全降低肺实质对LTB的反应,(pA2=7.2)[2]。LY255283(10μM,7天)可显著抑制253例J-BV膀胱癌细胞的侵袭性[4]。细胞活力测定[4]细胞系:253个J-BV细胞。浓度:5或10μM,培养时间:7天。结果:抑制BLT2信号可减弱253株J-BV细胞的侵袭性迁移。 |
体内研究 | LY255283(3,30mg/kg)可能通过以剂量依赖性的方式阻断激活的PMNs进入肺泡的募集,改善了脂多糖诱导的ARDS。LY255283(2.5mg/kg,ip)抑制小鼠移行细胞癌转移。结果表明,BLT2–Nox–ROS–NF–κB级联在膀胱癌的侵袭和转移中起关键作用[4]。动物模型:小鼠(注射253个J-BV细胞)[4]。剂量:2.5mg/kg。给药:注射细胞后3天和5天注射IP。结果:注射后12周,小鼠经LY255283处理后,每个肺仅形成0~3个结节,组织学分析证实微转移灶数量明显减少。 |
参考文献 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 573.4±60.0 °C at 760 mmHg |
熔点 | 160-162 °C |
分子式 | C19H28N4O3 |
分子量 | 360.451 |
闪点 | 300.6±32.9 °C |
精确质量 | 360.216156 |
PSA | 100.99000 |
LogP | 4.04 |
外观性状 | 固体 |
蒸汽压 | 0.0±1.6 mmHg at 25°C |
折射率 | 1.553 |
储存条件 | -20°C, 惰性气体 |
危害码 (欧洲) | F+ |
---|---|
危险品运输编码 | NONH for all modes of transport |
海关编码 | 2933990090 |
海关编码 | 2933990090 |
---|---|
中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Leukotriene B4 Inhibits L-Type Calcium Channels via p38 Signaling Pathway in Vascular Smooth Muscle Cells.
Cell Physiol. Biochem. 37 , 1903-13, (2015) Arachidonic acid (AA) and its metabolites are important endogenous lipid messengers. In this study, we test the effect of Leukotriene B4 (LTB4), a 5-lipoxygenase metabolite of AA, on L-type calcium ch... |
|
12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor.
J. Exp. Med. 211(6) , 1063-78, (2014) Leukotriene B4 (LTB4) receptor type 2 (BLT2) is a G protein-coupled receptor (GPCR) for 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT) and LTB4. Despite the well-defined proinflammatory roles... |
|
A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells.
Br. J. Cancer 109(2) , 351-9, (2013) Breast cancer is the most common malignancy in women. Although chemotherapeutic agents, such as paclitaxel, are effective treatments for the majority of breast cancer patients, recurrence is frequent ... |
1-(5-Ethyl-2-hydroxy-4-(6-methyl-6-(1H-tetrazol-5-yl)heptyloxy)phenyl)ethanone |
1-(5-Ethyl-2-hydroxy-4-{[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy}phenyl)ethanone |
Ethanone, 1-[5-ethyl-2-hydroxy-4-[[6-methyl-6-(2H-tetrazol-5-yl)heptyl]oxy]phenyl]- |